# Missouri Governor Considers Ban on THC Seltzers and Intoxicating Hemp Products > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/missouri-thc-seltzer-ban-hemp-product-restrictions/ > **Published:** 2026-04-02T20:31:51-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:31:36-04:00 > **Clinical Summary:** Explore the Missouri THC seltzer ban and its effects on intoxicating hemp products, patient access, and clinical guidance for healthcare providers. --- ✦ New CED Clinical Relevance #45 Clinical Context Background information relevant to the evolving [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) landscape. PolicyTHCHempSafetyIndustry Why This Matters Clinicians should understand that Missouri’s incoming ban on intoxicating hemp products will eliminate a category of cannabis products patients may currently be using for symptom management, potentially requiring dose adjustments or [medication alternatives](https://cedclinic.com/benzodiazepine-discontinuation-rates-medical-cannabis/). This regulatory shift affects the landscape of accessible cannabinoid products in Missouri and may influence patient counseling about legal options and potential substitution with FDA-regulated medications. Healthcare providers need to be prepared to discuss this change with patients who may face disrupted access to their current hemp-derived products. Clinical Summary Missouri is moving toward a regulatory ban on intoxicating hemp-derived products, including THC seltzers and other delta-8 and delta-10 containing beverages, effective November 12 if signed into law. This action reflects growing state-level concern about unregulated cannabis products that exploit federal legal loopholes, particularly those marketed with low oversight and high potency in formats appealing to younger consumers. The ban addresses [public health](https://cedclinic.com/cannabis-mold-contamination-risks-recall-safety/) gaps created when hemp-derived cannabinoids fall outside traditional cannabis regulations, leaving products with inconsistent labeling, potency verification, and safety standards. For clinicians, this regulatory shift signals increasing state efforts to control cannabinoid access and may reduce patient exposure to unlabeled or mislabeled intoxicating products, though patients currently using these products may face supply disruptions. Healthcare providers should anticipate patient questions about legal alternatives and may need to counsel patients on the distinction between regulated [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) and unregulated hemp products. Clinicians should stay informed about their own state’s regulatory landscape, as similar bans may follow in other states and affect how patients access or discuss cannabinoid use. Dr. Caplan’s Take “What we’re seeing with these hemp product bans is a necessary regulatory correction, because the current market is flooded with uncontrolled, unlabeled products of wildly inconsistent potency that patients can’t safely dose and that bypass the medical oversight we’ve built into the cannabis dispensary system. If Missouri passes this, it actually protects my patients who are trying to use cannabis therapeutically, since they’ll know exactly what they’re getting through legitimate channels rather than competing with black market products that claim to be ‘hemp’ but deliver unpredictable effects.” Clinical Perspective Missouri’s pending ban on intoxicating hemp products represents an emerging regulatory trend that clinicians should monitor, as it reflects growing public health concerns about unregulated cannabinoid products, particularly those marketed as beverages and easily accessible to younger populations. The regulatory landscape around hemp-derived THC remains fragmented across states, creating confusion for patients and practitioners alike regarding legal status, product quality, and standardized dosing. While such bans may reduce inadvertent exposure and ease-of-access issues, they do not address the underlying clinical management of patients with established [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) patterns or those using cannabis therapeutically in states where it remains legal. Clinicians should proactively discuss cannabis use with patients, particularly adolescents and young adults, remain informed about their state’s specific regulations, and understand the distinction between regulated medical cannabis and unregulated intoxicating hemp products when counseling about risks and alternatives. As regulatory action increases without parallel clinical 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just+read+this+on+CEDclinic.com%3A+Ban+on+THC+seltzers%2C+other+intoxicating+hemp+products+heads+to+Missouri+governor+-+KRCG+%40drcaplan&url=https%3A%2F%2Fkrcgtv.com%2Fnews%2Flocal%2Fban-on-thc-seltzers-other-intoxicating-hemp-products-heads-to-missouri-governor)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fkrcgtv.com%2Fnews%2Flocal%2Fban-on-thc-seltzers-other-intoxicating-hemp-products-heads-to-missouri-governor)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just+read+this%3A+Ban+on+THC+seltzers%2C+other+intoxicating+hemp+products+heads+to+Missouri+governor+-+KRCG+--+via+%40drcaplan.bsky.social+https%3A%2F%2Fkrcgtv.com%2Fnews%2Flocal%2Fban-on-thc-seltzers-other-intoxicating-hemp-products-heads-to-missouri-governor)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) Related Articles - [Hemp Beverage CEO: Even Legal Gummies Would Be Illegal to MAKE Under Container Rules](https://cedclinic.com/intermediate-product-rule-hemp-cbd-manufacturing-challenges/) 📰 Source: [https://krcgtv.com/news/local/ban-on-thc-seltzers-other-intoxicating-hemp-products-heads-to-missouri-governor](https://krcgtv.com/news/local/ban-on-thc-seltzers-other-intoxicating-hemp-products-heads-to-missouri-governor) Further Reading Research Digest[Research Digest: 5 Recent Studies – March 25, 2026](https://cedclinic.com/research-digest-recent-studies-march-2026/) Evidence Watch[Cannabinoid exposure during pregnancy: Cardiorespiratory effects and offspring outcomes.](https://cedclinic.com/prenatal-cannabinoid-exposure-effects-cardiorespiratory-health/) CED Clinic BlogFirst stop, the Moon. Next stop, Mars? Why Nasa’s mission matters [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Texas hemp businesses sue state over new ban on smokable THC products – CBS News](https://cedclinic.com/smokable-hemp-derived-thc-products-ban-texas/) Learn about Texas hemp businesses challenging new bans on smokable THC products and the legal landscape affecting hemp-derived cannabinoids. [Read More](https://cedclinic.com/smokable-hemp-derived-thc-products-ban-texas/) [With hemp rules tightening, users worry about access to THC-infused products](https://cedclinic.com/delta-8-thc-regulatory-changes-patient-access/) Explore concerns from users about access to THC-infused products amid tightening hemp regulations across states. [Explore Insights](https://cedclinic.com/delta-8-thc-regulatory-changes-patient-access/) [GOP Lawmaker Circulates Bill To Keep Hemp THC Drinks Federally Legal](https://cedclinic.com/gop-lawmaker-circulates-bill-to-keep-hemp-thc-drinks-federally-legal/) Discover legislative efforts aimed at maintaining federal legality of hemp THC drinks despite state-level bans. [Learn More](https://cedclinic.com/gop-lawmaker-circulates-bill-to-keep-hemp-thc-drinks-federally-legal/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).